In-brief: The FDA’s final guidance on cybersecurity for postmarket medical devicesmarks a departure from earlier drafts, focusing generically on cybersecurity risk management and jettisoning an early focus on the threat posed by “connected devices” that some considered too narrow.
In-brief: A prominent expert in medical device security has warned the FDA that its draft guidance for post market medical devices is too focused on stomping out known threats, and not enough on addressing current and future risks to the security of healthcare environments.
In-brief: Even with a high-profile summit in the heart of Silicon Valley, partisan gridlock back in Washington D.C. will make progress on cyber security impossible, experts say.
